微信关注
China
Total item
Cart Subtotal
￥ 0.00 产品详情
TG-101348是Janus相关激酶2的口服生物利用型，ATP竞争性和选择性抑制剂，在无细胞试验中IC50为3 nM，作用于JAK2比作用于JAK1和JAK3选择性高35和334倍,具有潜在的抗肿瘤活性。
靶点信息
| JAK2 (Cell-free assay) | JAK2 (V617F) (Cell-free assay) | FLT3 (Cell-free assay) | RET (Cell-free assay) | |
| 3 nM | 3 nM | 15 nM | 48 nM |
| In vitro (25°C) | DMSO | 100 mg/mL (190.59 mM) | |
| Water | <1 mg/mL (<1 mM) | ||
| Ethanol | <1 mg/mL (<1 mM) | ||
| In vivo | 1% DMSO/30% polyethylene glycol/1% Tween 80 | 30 mg/mL | |
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 19.06 mL | 95.29 mL | 190.59 mL |
| 0.5 mM | 3.81 mL | 19.06 mL | 38.12 mL |
| 1 mM | 1.91 mL | 9.53 mL | 19.06 mL |
| 5 mM | 0.38 mL | 1.91 mL | 3.81 mL |
*The above data is based on the productmolecular weight 524.7. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
| 目录号 | A11082 |
|---|---|
| MECHANISM OF ACTION | Inhibitor |
| M. Wt | 524.7 |
| Formula | C27H36N6O3S |
| Solubility | DMSO |
| Purity | >98% |
| Storage | at -20°C 3 years Powder |
| CAS No. | 936091-26-8 |
| Synonyms | SAR302503,TG101348,TG101348 |
| SMILES | CC1=CN=C(N=C1NC2=CC(=CC=C2)S(=O)(=O)NC(C)(C)C)NC3=CC=C(C=C3)OCCN4CCCC4 |
产品资料
产品标签
Product Questions
Product Questions
No Questions
您还可能对下列产品感兴趣
AC220 (Quizartinib)
AC220 (Quizartinib)是一种有效的选择性FLT3抑制剂，对于MC4-11和A375，IC50分别为0.56±0.3 nM和> 10 mM。
AZD 2932
AZD2932 is a potent and mutil-targeted protein tyrosine kinase inhibitor with IC50 of 8 nM, 4 nM, 7 nM, and 9 nM for VEGFR-2, PDGFRβ, Flt-3…
SGI-1776 (free base)
SGI-1776 (free base)是Pim1的一种新型ATP竞争性抑制剂，在无细胞试验中的IC50为7 nM，选择性是Pim2和Pim3的50倍和10…
Pexidartinib (PLX3397)
Pexidartinib is a small-molecule receptor tyrosine kinase (RTK) inhibitor of KIT, CSF1R and FLT3 with potential antineoplastic activity.
Keywords:购买 TG-101348 (Fedratinib, SAR302503) | TG-101348 (Fedratinib, SAR302503) 供应商 | 订购 TG-101348 (Fedratinib, SAR302503) | TG-101348 (Fedratinib, SAR302503) 价格 | TG-101348 (Fedratinib, SAR302503) 生产商 | 订单 TG-101348 (Fedratinib, SAR302503) | TG-101348 (Fedratinib, SAR302503) 代理商 | 购买 936091-26-8| 936091-26-8 供应商 | 订购 936091-26-8 | 936091-26-8 价格 | 936091-26-8 生产商 | 订单 936091-26-8 | 936091-26-8 代理商|buy TG-101348 (Fedratinib, SAR302503) | TG-101348 (Fedratinib, SAR302503) Supplier | purchase TG-101348 (Fedratinib, SAR302503) | TG-101348 (Fedratinib, SAR302503) cost | TG-101348 (Fedratinib, SAR302503) manufacturer | order TG-101348 (Fedratinib, SAR302503) | TG-101348 (Fedratinib, SAR302503) distributor | buy 936091-26-8| 936091-26-8 Supplier | purchase 936091-26-8 | 936091-26-8 cost | 936091-26-8 manufacturer | order 936091-26-8 | 936091-26-8 distributor
联系我们
United StatesAdooq Bioscience
Toll Free: (866) 930-6790
Fax: +1-323-606-8156
Email: sales@adooq.com
Not your Region? View all Distributors
ADOOQ 产品质量保证
We promise all products to perform as described.